CCNA1, a key regulator of cell cycle dynamics, is critically involved in the progression of melanoma, making it a promising target for therapeutic intervention. By using antibody-conjugated liposomes specifically designed to bind to CCNA1, researchers aim to disrupt the normal proliferation of melanoma cells, effectively stalling their ability to divide. This innovative strategy not only targets cancer cells more precisely but also induces cell cycle arrest, thereby slowing down or potentially halting tumor growth and enhancing the overall effectiveness of cancer treatment.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-3727z | Mouse Anti-CCNA1 Recombinant Antibody (clone 20B12) | WB, IP, IF, IHC, ELISA | Mouse IgG2a, κ |
MOB-2073MZ | Recombinant Mouse Anti-Xenopus laevis ccna1 Antibody (clone YMB2-4) | WB | Mouse antibody |
There are currently no Customer reviews or questions for VS-1024-FY165. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.